Goodbye message: Califf says FDA needs help in battling misinformation, has deep talent pool to mitigate departures
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyCBERCDERMedical DevicesPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)